Cathie Wood Offloads Millions in Roku and Archer Aviation Stocks
ByAinvest
Wednesday, Jul 16, 2025 2:10 am ET1min read
ACHR--
In contrast, ARK's ARKG ETF purchased 52,527 shares of Caris Life Sciences, totaling $1,392,490. This marks a new investment direction for the fund, which has not reported significant activity in Caris Life Sciences in the previous week’s trades. The purchase indicates growing confidence in the biotechnology sector, despite ongoing sell-offs in other healthcare-related stocks [1].
ARKK ETF also sold 171,557 shares of Archer Aviation Inc (ACHR), totaling $1,803,064. This follows a similar sale from the previous Friday, suggesting a consistent sell-off strategy for the aviation company [1].
These trades reflect ARK’s dynamic investment approach, as it continues to adjust its portfolios based on evolving market conditions. Investors following ARK’s ETFs should note these ongoing trends and consider the fund's strategic moves in their investment decisions.
References:
[1] https://www.investing.com/news/company-news/cathie-woods-ark-sells-roku-buys-caris-life-sciences-stock-93CH-4134564
ARKK--
CAI--
ROKU--
Cathie Wood's ARK Invest ETFs sold a combined $3.02 million worth of Roku (ROKU) shares, continuing a trend of reducing exposure to the stock. Meanwhile, Wood added $1.39 million worth of Caris Life Sciences (CAI) shares, signaling growing confidence in the biotechnology sector. Archer Aviation (ACHR) stock sales also increased, with Wood trimming the fund's exposure to the eVTOL aircraft maker despite growing interest in the sector.
ARK Invest ETFs, led by Cathie Wood, have made significant adjustments to their portfolios, with notable trades in Roku Inc (ROKU) and Caris Life Sciences Inc (CAI). On Monday, July 14th, 2025, ARK's ETFs sold a combined $3,022,367 worth of Roku shares, continuing a trend of reducing exposure to the stock [1]. This move follows a series of sales over the past week, signaling a potential shift in the fund's confidence in the streaming device company.In contrast, ARK's ARKG ETF purchased 52,527 shares of Caris Life Sciences, totaling $1,392,490. This marks a new investment direction for the fund, which has not reported significant activity in Caris Life Sciences in the previous week’s trades. The purchase indicates growing confidence in the biotechnology sector, despite ongoing sell-offs in other healthcare-related stocks [1].
ARKK ETF also sold 171,557 shares of Archer Aviation Inc (ACHR), totaling $1,803,064. This follows a similar sale from the previous Friday, suggesting a consistent sell-off strategy for the aviation company [1].
These trades reflect ARK’s dynamic investment approach, as it continues to adjust its portfolios based on evolving market conditions. Investors following ARK’s ETFs should note these ongoing trends and consider the fund's strategic moves in their investment decisions.
References:
[1] https://www.investing.com/news/company-news/cathie-woods-ark-sells-roku-buys-caris-life-sciences-stock-93CH-4134564
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet